Serious adverse events from generic drugs are underreported due to systemic gaps in labeling and tracking. Learn how the current reporting system works, why it fails, and what you can do to improve safety.
Drug safety signals reveal hidden risks that clinical trials miss. Learn how real-world data, statistical tools, and AI are used to detect adverse reactions after drugs reach the market.